These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30742714)

  • 1. Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres.
    Maughan NM; Garcia-Ramirez J; Arpidone M; Swallen A; Laforest R; Goddu SM; Parikh PJ; Zoberi JE
    Med Phys; 2019 May; 46(5):2394-2402. PubMed ID: 30742714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a commercial software dose calculation for Y-90 microspheres.
    Guerrero M; Yao W; Lin M; Becker SJ; Molitoris JK; Vedam S; Yi B
    Brachytherapy; 2022; 21(4):561-566. PubMed ID: 35537917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
    D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
    Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of imaging
    Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
    Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET-CT post therapy dosimetry in radioembolization with resin
    Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
    Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of image reconstruction method on dose distributions derived from
    Hou X; Ma H; Esquinas PL; Uribe C; Tolhurst S; Bénard F; Liu D; Rahmim A; Celler A
    Phys Med Biol; 2020 Nov; 65(21):215022. PubMed ID: 33245057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the voxel-based approaches in radioembolization dosimetry with reDoseMC.
    Kim TP; Enger SA
    Med Phys; 2024 Jun; 51(6):4007-4027. PubMed ID: 38703394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET.
    Tafti BA; Padia SA
    Semin Nucl Med; 2019 May; 49(3):211-217. PubMed ID: 30954187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
    D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
    Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective SPECT/CT dosimetry following transarterial radioembolization.
    Thompson BC; Dezarn WA
    J Appl Clin Med Phys; 2021 Apr; 22(4):143-150. PubMed ID: 33710776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Dosimetry for Liver Cancer Y-90 Radioembolization Using Computational Fluid Dynamics and Monte Carlo Simulation.
    Roncali E; Taebi A; Foster C; Vu CT
    Ann Biomed Eng; 2020 May; 48(5):1499-1510. PubMed ID: 32006268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.
    Pacilio M; Ferrari M; Chiesa C; Lorenzon L; Mira M; Botta F; Becci D; Torres LA; Coca Perez M; Vergara Gil A; Basile C; Ljungberg M; Pani R; Cremonesi M
    Med Phys; 2016 Jul; 43(7):4053. PubMed ID: 27370124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization Dosimetry with Total-Body
    Costa G; Spencer B; Omidvari N; Foster C; Rusnak M; Hunt H; Caudle DT; Pillai RT; Vu CT; Roncali E
    J Nucl Med; 2022 Jul; 63(7):1101-1107. PubMed ID: 34795015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
    Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG
    J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of
    Balagopal A; Kappadath SC
    Med Phys; 2018 Feb; 45(2):875-883. PubMed ID: 29172243
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
    Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
    Tapp KN; Lea WB; Johnson MS; Tann M; Fletcher JW; Hutchins GD
    J Nucl Med; 2014 Sep; 55(9):1452-8. PubMed ID: 24982437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Tumor Control in
    Dewaraja YK; Devasia T; Kaza RK; Mikell JK; Owen D; Roberson PL; Schipper MJ
    J Nucl Med; 2020 Jan; 61(1):104-111. PubMed ID: 31147404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for
    Trotta N; Collette B; Mathey C; Vierasu I; Bucalau AM; Verset G; Moreno-Reyes R; Goldman S
    Med Phys; 2022 Dec; 49(12):7567-7582. PubMed ID: 35894818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.